Obiettivo
HeCaToS aims at developing integrative in silico tools for predicting human liver and heart toxicity. The objective is to develop an integrated modeling framework, by combining advances in computational chemistry and systems toxicology, for modelling toxic perturbations in liver and heart across multiple scales. This framework will include vertical integrations of representations from drug(metabolite)-target interactions, through macromolecules/proteins, to (sub-)cellular functionalities and organ physiologies, and even the human whole-body level. In view of the importance of mitochondrial deregulations and of immunological dysfunctions associated with hepatic and cardiac drug-induced injuries, focus will be on these particular Adverse Outcome Pathways. Models will be populated with data from innovative in vitro 3D liver and heart assays challenged with prototypical hepato- or cardiotoxicants; data will be generated by advanced molecular and functional analytical techniques retrieving information on key (sub-)cellular toxic evens. For validating perturbed AOPs in vitro in appropriate human investigations, case studies on patients with liver injuries or cardiomyopathies due to adverse drug effects, will be developed, and biopsies will be subjected to similar analyses. Existing ChEMBL and diXa data infrastructures will be advanced for data gathering, storing and integrated statistical analysis. Model performance in toxicity prediction will be assessed by comparing in silico predictions with experimental results across a multitude of read-out parameters, which in turn will suggest additional experiments for further validating predictions. HeCaToS, organized as a private-public partnership, will generate major socioeconomic impact because it will develop better chemical safety tests leading to safer drugs, but also industrial chemicals, and cosmetics, thereby improving patient and consumer health, and sustaining EU’s industrial competitiveness.
Campo scientifico
Argomento(i)
Invito a presentare proposte
FP7-HEALTH-2013-INNOVATION-1
Vedi altri progetti per questo bando
Meccanismo di finanziamento
CP-IP - Large-scale integrating projectCoordinatore
6200 MD Maastricht
Paesi Bassi
Mostra sulla mappa
Partecipanti (13)
4070 Basel
Mostra sulla mappa
8952 Schlieren
Mostra sulla mappa
46026 Valencia
Mostra sulla mappa
8092 Zuerich
Mostra sulla mappa
SW7 2AZ LONDON
Mostra sulla mappa
T12 Cork
Mostra sulla mappa
69117 Heidelberg
Mostra sulla mappa
4053 BASEL
Mostra sulla mappa
80539 Munchen
Mostra sulla mappa
WC2R 2LS London
Mostra sulla mappa
52062 Aachen
Mostra sulla mappa
10405 Berlin
Mostra sulla mappa
CB25 9PB Cambridge
Mostra sulla mappa